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Abstract 
Caveolinopathies, caused by CAV3 mutations, can include several phenotypes such as rippling muscle disease, limb-girdle muscular 
dystrophy type 1C, distal myopathy, familial hypertrophic cardiomyopathy, and idiopathic hyperCKemia. Here we present characteristic 
skeletal muscle imaging findings in four patients with genetically defined childhood-onset RMD caused by CAV3 mutations and in one 
patient with congenital generalized lipodystrophy type 4 with muscular dystrophy due to polymerase I and transcript release factor (PTRF ) 
mutations, which may have caused secondary deficiency of caveolin-3. Muscle MRI revealed that the rectus femoris and semitendinosus 
muscles were most commonly affected in the rippling muscle disease patients. Peripheral changes in the rectus femoris were specific and 
observed even in one of the younger patients in this study. Furthermore, muscle involvement extended to the semitendinosus muscles, biceps 
femoris, and gracilis with disease progression or increase in its severity. Similar patterns of involvement were observed on reviewing skeletal 
muscle images of various previously reported phenotypes of caveolinopathy; interestingly, patients with secondary deficiency of caveolin due 
to PTRF mutations revealed the same pattern. Thus, primary caveolinopathies and secondary deficiency of caveolin demonstrated specific 
findings on skeletal muscle imaging, regardless of the broad phenotypic spectrum of these two conditions. 
© 2018 Elsevier B.V. All rights reserved. 
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Polymerase I and transcript release factor. 
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0. Introduction 
Caveolins are important components of uncoated plasma
embrane invaginations that regulate both signal transduc-
ion and vesicular trafficking [1] . Mutations in the CAV3
ene encoding caveolin-3 that maps to chromosome 3p25
an produce several phenotypes, including Rippling mus-∗ Corresponding author. 
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960-8966/© 2018 Elsevier B.V. All rights reserved. le disease (RMD), limb-girdle muscular dystrophy type 1C
LGMD1C), distal myopathy, familial hypertrophic cardiomy- 
pathy, and idiopathic hyper creatine kinasemia (hyperCK-
mia) [2,3] . The clinical phenotypes may overlap each other
ithin the same individual or in individuals within the same
amily and present with the same mutations in CAV3 ; thus,
he genotype-phenotype correlation remains unclear [4] . 
RMD is a rare autosomal dominant disorder, characterized
y signs of increased muscle irritability. These signs, which
ive RMD its name include percussion-induced rapid contrac-
ion, percussion-induced localized muscle mounding, and/or 
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o  percussion/ stretching-induced rolling movements across a
muscle group (muscle rippling) [5] . Patients with RMD may
begin to suffer from muscle cramps, pain, and stiffness during
the first or second decade of their lives. Despite normal mus-
cle strength, patients with RMD are often unable to sit down
on their heels, and toe walking is a common observation. Re-
cently, congenital generalized lipodystrophy type 4 with mus-
cular dystrophy (CGL4) due to polymerase I and transcript
release factor (PTRF ) mutations, has been reported (OMIM
#613,327). Patients with PTRF deficiency present with loss
of subcutaneous adipose tissues from birth, manifestations of
muscular dystrophy, arrhythmia, and several other symptoms
[6] . Secondary reduction of caveolin-3 may progress with
age or disease progression, and percussion-induced muscle
mounding is a characteristic finding in patients with PTRF
deficiency as well as in patients with RMD caused by CAV3
mutations. 
Several skeletal muscle-imaging studies have recently been
reported for differential diagnosis and assessment of the pro-
gression of each distinct neuromuscular disorder. T1-weighted
(T1W) skeletal muscle magnetic resonance imaging (MRI) of
the lower limbs in genetically distinct neuromuscular disor-
ders have identified specific patterns characteristic to these
neuromuscular diseases. To date, there have been a few re-
ports on specific muscle MRI patterns in patients with cave-
olinopathies. Herein, we present characteristic skeletal MRI
findings in four patients with childhood-onset RMD, who
were identified with known CAV3 mutations, and in one pa-
tient with CGL4, who developed secondary caveolin-3 de-
ficiency due to PTRF deficiency. In addition, we reviewed
skeletal muscle imaging examinations of previously reported
caveolinopathies. 
2. Material and methods 
Muscle MRI was performed using conventional T1
weighted spin echo on a 1.5-tesla TOSHIBA or Philips MR
scanner. Non-contrast images of the thighs and legs were ob-
tained. The axial plane was selected with respect to the long
axis of the body. The thickness of the slices ranged from 5
to 10 mm with a gap of 10–20 mm between each slice. A
fast gradient echo was used for pilots, whereas a spin echo
pulse sequence was used for the images (repetition time [TR],
424–696 ms; echo time [TE], 10–18 ms; row matrix 320–512
points; column matrix, 219–512 points; and variable field of
view [FOV], 25–40 cm). The average total examination time
was 30 min per patient. Skeletal muscle MRI was evaluated
by a radiologist, a neurologist, and two pediatric neurologists.
Individual muscles of the patients were analyzed; the involve-
ment of 19 muscles in the leg (12 in the thigh and 7 in the
lower leg) were assessed and categorized using the Mercuri
score [7] as follows: Stage 0, normal appearance; Stage 1,
scattered small areas of increased density; Stage 2a, numer-
ous discrete areas of increased density less than 30% of the
volume of the muscle; Stage 2b, numerous discrete areas of
increased density with early confluence (30%–60% of the vol-
ume of the muscle); Stage 3, washed-out appearance due toonfluent areas of increased density with muscle still present
t the periphery; and Stage 4, end-stage appearance with mus-
le entirely replaced by areas of increased density. The pat-
erns of each of the affected muscles were classified accord-
ng to the Treat-NMD workshop report as follows: Stage 0–1,
lack; Stage 2a–2b, gray; and Stage 3–4, white ( Figs. 1 and
 ; cross sections of thigh and calf) [7,8] . 
. Case description 
.1. Case 1 
Case 1 was a 28-year-old woman, who had an elder brother
ith epilepsy, but no skeletal muscle symptoms; her parents
nd an elder sister were also asymptomatic ( Fig. 3 (a)). His-
ory revealed that she would fall down very often at 5–6 years
f age. At 11 years of age, she started to complain of muscle
ain in the thigh after exercise, which was followed by rapid
rogression of calf muscle hypertrophy. At the age of 12, she
as found to have a high serum CK level (14,171 U/L). Neu-
ological evaluation revealed moderate muscle weakness of
he neck anteflexion (3/5) and mild muscle weakness (4/5) in
he proximal limb muscles. She showed symptoms like weak
rip and apparent percussion myotonia. Deep tendon reflexes
ere slightly hyperactive in all extremities. She was unable
o sit down on her heels due to calf muscle hypertrophy.
uscle CT revealed atrophic and moth-eaten changes in the
ectus femoris, hamstrings, and gastrocnemius, with hyper-
rophy of the vastus lateralis and paraspinal muscles. Fig. 4
resents her skeletal muscle CT at 18 years of age. Muscle
iopsy revealed moderate muscle fiber size variation, a few
ecrotic and regenerating fibers, and moderate endomysial
brosis. The number of internal nuclei was increased and
mmunohistochemistry revealed that the cells were negative
or caveolin-3. The subject continued to experience stiffness
nd cramps with gradual progression of limb-girdle muscle
eakness. At 28 years of age, she complained of difficulty
n jumping and climbing upstairs, and thus, skeletal muscle
RI images were obtained ( Figs 1 and 2 ). Genetic analy-
is revealed a CAV3 mutation: p. Glu47Asp, which has been
eported to cause RMD [2] . 
.2. Cases 2 and 3 
Cases 2 and 3 were siblings, an 8-year-old and a 6-year-
ld boy, respectively. At 9 months of age, the proband case
Case 3) was evaluated for motor development delay. He was
nable to sit without support and mild muscle weakness was
oted. At 17 months, elevated serum CK levels (500–800 U/L)
ere observed. He had been unable to jump at 2 years and
 months of age, and experienced muscle pain after exercise
nd upon awakening at the age of 4 years and 8 months. He
acked the strength to unscrew bottle caps. Neurological eval-
ation revealed isolated muscle weakness in the anteflexion
f the neck (3/5). He showed calf hypertrophy and difficulty
ending the ankle joints. Symptoms similar to percussion my-
tonia such as mounding of his leg muscles and rippling were
K. Ishiguro et al. / Neuromuscular Disorders 28 (2018) 857–862 859 
Fig. 1. Muscle MRI findings and classification according to the Mercuri score of Thigh. T1W muscle MRI imaging (upper) and the schema (lower) of the 
affected muscles of the thigh (a) of each of the four cases. The schema indicates the pattern of muscles affected based on the individual muscles assessed. 
The finding was graded according to the Mercuri score as follows: Stage 0–1, presented as black color; Stage 2a–2b, gray; and Stage 3–4, white. The rectus 
femoral, sartorius, and biceps femoral muscles appeared shrunken and irregular in shape with indentations between the muscles and the connective tissue 
resulting in a wrinkled effect on the MR images. 
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wetected. Deep tendon reflexes were normal. Gower’s sign
as negative. Muscle biopsy at the age of 3 years indicated
oderate muscle fiber size variation, few necrotic and regen-
rating fibers, and moderate endomysial fibrosis. The number
f internal nuclei was increased and the cells were negative
or caveolin-3. Family history revealed that both his mother,
6 years old at presentation, and his elder brother (Case 2),
ad muscle pain and stiffness ( Fig. 3 (b)). His mother had
ften experienced leg cramps since elementary school. 
The 8-year-old boy (Case 2) presented with calf muscle hy-
ertrophy and complained of muscle pain after school. Both
e and his mother showed mounding of the lower legs. The
everity of increased muscle irritability in Case 2 was more
emarkable than that in Case 3. Skeletal muscle MRI was
erformed for Cases 2 and 3 at 8 and 4 years of age, respec-
ively ( Figs. 1 and 2 ). Genetic analysis revealed the presence
f a mutation in CAV3 : p. Arg27Gln in the two boys and
heir mother. This mutation has previously been associated
ith RMD [9,10] . 
.3. Case 4 
Case 4 was a 2-year-old girl, who was born as a very low
irth weight infant with aortic coarctation ( Fig. 3 (c)). At 3onths of age, elevated CK levels (1417 U/L) were observed
hen she underwent catheter treatment for the cardiac prob-
em. She showed mild motor developmental delay, such as
ained head control at 5 months and walking at 21 months of
ge. The subject presented with hyperreflexia, which included
he biceps and triceps reflex, patellar reflex, and Achilles ten-
on reflex. She showed symptoms similar to percussion my-
tonia and apparent mounding. Her father was also noticed
o have mild mounding, rippling, and thigh and calf muscle
ypertrophy. He could not sit down on his heels, although
is symptoms were much milder than that of his daughter.
enetic analysis of the patient and her father revealed the
resence of a mutation in CAV3 : p. Arg27Gln, which was the
ame as that seen in Cases 2 and 3. Skeletal muscle MRI was
erformed for Case 4 at 2 years of age ( Figs. 1 and 2 ). 
.4. Case 5 
Case 5 was a 3-year-old boy with CLG4 caused by
TRF mutations [11] . He showed delayed motor develop-
ent (started walking at 2 years and 6 months of age) and
nsulin resistance (at 3 years of age). He presented with a
omozygous c.696_697insC mutation in PTRF . Muscle CT
as evaluated at the age of 3 years ( Fig. 5 ). 
860 K. Ishiguro et al. / Neuromuscular Disorders 28 (2018) 857–862 
Fig. 2. Muscle MRI findings and classification according to the Mercuri score of Calf. T1W muscle MRI imaging (upper) and the schema (lower) of the 
affected muscles of the calf of each of the four cases, as Fig. 1 . Only Case 1 showed mild changes in the gastrocnemius muscles. 
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c4. Results 
Skeletal Muscle MRI ( Figs. 1 and 2 ) and CT scans ( Figs. 3
and 4 ) 
Muscle CT scans of Case 1 at 18 years of age revealed
atrophic and moth-eaten changes in the rectus femoris, ham-
strings, and gastrocnemius ( Fig. 4 ). 
Changes in T1-weighed skeletal muscle MRI scans of the
thigh and calf muscles were evaluated. In Case 1, MRI scans
of the skeletal muscles of the calves were obtained a few
years after those of the thighs. The pattern of changes was
found to be similar in all four cases ( Fig. 1 ). Case 1 showed
diffuse changes mainly in the rectus femoris, sartorius, bi-
ceps femoris, and semitendinosus muscles. In addition, mild
changes were noted in the semimembranosus and gastrocne-Fig. 3. Family trees of the four patients. (a) Case 1, (b) Case 2, (c) Case ius muscles. The rectus femoris and semitendinosus muscles
ere also affected in Case 2. The vastus medialis, but not the
alf muscles, were also involved. The most marked changes
n Case 3 included peripheral changes in the rectus femoris
nd atrophy of the semitendinosus muscles, whereas the bi-
eps femoris was very mildly affected. The youngest patient
n the current study (Case 4) had already demonstrated appar-
nt peripheral changes in the rectus femoris. In fact, changes
n rectus femoris were commonly noticed in all four cases in
his study. The changes were more diffuse in Case 1, whereas
n the other three cases, atrophic or peripheral changes form-
ng ring-like patterns were noted in the rectus femoris. 
Muscle CT images from Case 5 revealed peripheral in-
olvement of the rectus femoris and marked reduction in sub-
utaneous adipose tissue ( Fig. 5 ). 4 . ND: mutations were not detected. NA: patients were not analyzed. 
K. Ishiguro et al. / Neuromuscular Disorders 28 (2018) 857–862 861 
Fig. 4. Muscle CT scan images of Case 1 aged 18 years old. Muscle CT scan 
revealed atrophic and moth-eaten changes in the rectus femoris, hamstrings, 
and gastrocnemius. 
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Fig. 5. Muscle CT image of the patient with PTRF deficiency. Muscle CT 
image of the 3-year-old boy with PTRF deficiency. Atrophic or peripheral 
fatty changes were observed in the rectus femoris only. 
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In recent years, the importance of clinical muscular imag-
ng in patients with suspected or proven inherited muscle
iseases has increasingly been recognized [12] . The specific
atterns of skeletal muscle imaging facilitate differential diag-
osis in some muscular dystrophies. To date, there have been
 few reports on skeletal muscle imaging in patients with
aveolinopathies; most patients with RMD demonstrated nor-
al skeletal muscle imaging [13] . In the present study, we
eported four patients, including young children from three
amilies, with childhood-onset RMD. The striking findings of
his study using skeletal muscle MRI were that the peripheral
ectus femoris and semitendinosus muscles were affected in
he four childhood-onset RMD patients. The rectus femoris,
n particular, showed atrophic or peripheral involvement in aing-like pattern, which appears to be specific for this dis-
ase. Careful review of previous case reports revealed that
eripheral changes in the shape of the rectus femoris mus-
le and diffuse changes in the semitendinosus muscle were
ommon in patients with RMD [13,14] . Scalco et al. reported
hat only one (a 12-year-old boy) of the eight patients in
heir study had presented with abnormal MRI findings (mild
nvolvement of the rectus femoris, sartorius, biceps femoris,
astrocnemius, and semitendinosus muscles); the remaining 
atients had demonstrated normal muscle images or not been
ested. In another case report on a family with RMD, a 28-
ear-old male presented with striking symmetric lipomatous
egeneration of the distal parts of the rectus femoris, and
ild changes in the semitendinosus muscles, similar to Case
 in the current study. In another report involving a 39-year-
ld Japanese male with RMD and extraocular muscle paresis,
eripheral changes in the rectus femoris and mild changes
n the semitendinosus muscles were clearly noticeable in the
gure, although the authors had not commented on them in
he original report [14] . 
We evaluated muscle involvement changes specific to var-
ous stages ranging from early infancy to adulthood in RMD
nd identified a correlation between the degree of muscle in-
olvement and the age or stage. The rectus femoris and semi-
endinosus muscles were most affected in all four cases, al-
hough the range of involvement increased as the disease pro-
ressed with age (Case 1). Furthermore, the pattern of muscle
RI involvement was detectable even in a toddler (Case 4),
here the change was detected only in the rectus femoris,
hereas in school-aged children, the muscle involvement had
xpanded from the rectus femoris to the semitendinosus and
862 K. Ishiguro et al. / Neuromuscular Disorders 28 (2018) 857–862 
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 sartorius muscles. Interestingly, Case 1, the most severely af-
fected adult patient with muscle weakness, showed high T1W
signal intensities extending to the semimembranosus, biceps
femoris, gracilis, adductor longus, and gastrocnemius muscles.
In previous reports, adult patients with RMD showed abnor-
mal MRI findings in not only the rectus femoris and semi-
tendinosus muscles but also in the semimembranosus, biceps
femoris, gracilis, and tibialis anterior muscles. Patients with
prominent signs of RMD or those with overlapping LGMD
1C tended to show diffused and marked involvement in the
skeletal muscle MRI [4,15] . Case 1 developed muscle weak-
ness during adulthood, which could be classified as overlap-
ping of RMD and LGMD1C. The widespread muscle involve-
ment in the MRI findings might suggest the progression of the
disease with aging in this patient (Case 1); in addition, it may
indicate the severity of the disease or the signs of overlap with
LGMD1C. However, the number of patients in this study was
small. Longitudinal studies with increased number of RMD
cases showing muscle involvement via MRI are necessary to
establish the characteristic MRI findings of this disease. 
On the other hand, the muscle CT scans in patients with
CGL4 due to PTRF mutations showed similar patterns to
those seen in patients with caveolinopathies. One of the clini-
cal features of patients with PTRF mutations was percussion-
induced muscle mounding, a characteristic feature of RMD.
PTRF mutations cause PTRF deficiency, which may lead to
secondary deficiency of caveoline-3 with disease progression.
Interestingly, the patterns of skeletal muscle involvement in
patients with secondary deficiency of caveolin-3 (due to PTRF
mutations) were similar to that seen in patients with primary
caveolinopathies. Further studies involving a larger number
of cases are required to evaluate the progression of involve-
ment patterns of the muscles in patients with secondary cave-
olinopathy 
6. Conclusion 
In conclusion, characteristic MRI findings appear to be
useful for the diagnosis of caveolinopathies, especially in
childhood-onset RMD. Longitudinal studies involving more
cases with caveolinopathies and secondary deficiency of
caveoline-3 are merited to confirm the findings of the cur-
rent study. cknowledgment 
This work was supported by Intramural Research Grant
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